Nektar Therapeutics (NKTR) shares were up more than 26% in recent trading Friday after Jefferies upgraded the stock to buy from hold and raises price target to $2 per share from $1.
Trading volume was 6.3 million shares, compared with a daily average of 2.2 million.
Price: 0.63, Change: +0.13, Percent Change: +26.25
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.